Providence Montana - HealthBreak - RESOLVE

March 27, 2026

Share this Video
Facebook

Providence Montana - HealthBreak - RESOLVE RESOLVE is the name of a new collaborative between Providence Health, Providence St. Patrick Hospital, and the University of Montana aimed at improving healthcare in rural locations. Interventional Cardiologist & Chief Medical Officer Dr. Daniel Spoon explains. Daniel Spoon, MD Interventional Cardiologist Montana.Providence.org (406) 327-1700 HealthBreak®© 2026, MBC Media®© 2026 Saint Patrick Hospital, Providence Saint Patrick Hospital, Providence Montana, HealthBreak® ©2026, Medical News, MBC Media® ©2026, Missoula Montana, Daniel Spoon, MD, Interventional Cardiologist, RESOLVE

In groundbreaking heart valve trial, Providence Swedish is recognized as a global leader

The MR Repair trial ranks Providence Swedish's echocardiography lab as a top-performing site for the advanc...

Providence research in the news: cancer research equity toolkit featured in Becker's Oncology

A recent Beckers Health interview with Providence researcher Kristi Roybal, PhD, showcases the launch of an...

Other content in this Stream

New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities

Providence Montana - HealthBreak - RESOLVE

Previous Article

Next Article

Other content in this Stream

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence researchers conducted over 1500 studies in 2025, according to a new report from the Providence Research Network. Check out the 2025 research program brief to learn more!

A new study focused on stories will change health outcomes for Black women.

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

New research from CORE and Providence Genomics asks whether how and where genetic testing is offered affects whether patients say “yes.”

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.

After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more

The MR Repair trial ranks Providence Swedish's echocardiography lab as a top-performing site for the advancement of mitral valve care. Learn more.

A recent Beckers Health interview with Providence researcher Kristi Roybal, PhD, showcases the launch of an interactive toolkit to help health systems boost equity in medical research.

Learn how Providence researchers are providing valuable real-world data on the transition to next-generation nursing models.

Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients

CORE's 2025 Annual Report showcases how CORE and its cross-sector partners are working to advance health and health equity across the Western U.S. and beyond.

A generous grant from the Kuni Foundation is helping Providence researchers better understand lung cancer symptoms and improve patients' quality of life.

The study may redefine care for many people at the earliest stage of their treatment.

Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.

2025 marked several exciting milestones for our efforts to expand access to cancer and stroke research in West Texas through Covenant Health

A major new study published in the prestigious journal Nature Medicine is offering renewed hope for cancer patients whose disease no longer responds to immunotherapy, and Providence St. Jude is proud